- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour suppressor genes in chemotherapeutic drug response
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 32, Issue 4, Pages 361-374
Publisher
Portland Press Ltd.
Online
2012-04-23
DOI
10.1042/bsr20110125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors
- (2015) Stuart J. Gallagher et al. NEOPLASIA
- The Rb Pathway and Cancer Therapeutics
- (2012) W. Du et al. CURRENT DRUG TARGETS
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer
- (2011) Junan Li et al. BIOCHEMISTRY
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
- (2011) Inthrani R. Indran et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Mechanism of Cell Adaptation
- (2011) Valentina Fodale et al. CANCER JOURNAL
- Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
- (2011) P. Papageorgis et al. CANCER RESEARCH
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- Negative Regulation of the Hippo Pathway by E3 Ubiquitin Ligase ITCH Is Sufficient to Promote Tumorigenicity
- (2011) Z. Salah et al. CANCER RESEARCH
- p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation
- (2011) S. Huang et al. CANCER RESEARCH
- Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells
- (2011) I.-W. Teng et al. CANCER RESEARCH
- SnapShot: The Hippo Signaling Pathway
- (2011) Caroline Badouel et al. CELL
- RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents
- (2011) Kristy R. Stengel et al. CELL CYCLE
- MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
- (2011) N. Nishida et al. CLINICAL CANCER RESEARCH
- Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance
- (2011) Gopeshwar Narayan et al. GENES CHROMOSOMES & CANCER
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer
- (2011) Ewa Malgorzata Michalak et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- YAP and TAZ feel the force
- (2011) Katharine H. Wrighton NATURE REVIEWS MOLECULAR CELL BIOLOGY
- p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
- (2011) C Romagosa et al. ONCOGENE
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
- (2011) K. C. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC, PARP1, and Chemoresistance: BIN There, Done That?
- (2011) S. Ganesan Science Signaling
- A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
- (2011) N. Suwaki et al. Science Translational Medicine
- PTEN, PIK3CA, p-AKT, and p-p70S6K Status
- (2010) Francisco J. Esteva et al. AMERICAN JOURNAL OF PATHOLOGY
- Increased expression of p27 is associated with the cisplatin resistance in gastric cancer cell line YCC-3
- (2010) Tuong Vy Thi Le et al. ARCHIVES OF PHARMACAL RESEARCH
- Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways
- (2010) Heiko M. Mundt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
- (2010) Junxia Wei et al. BMC CANCER
- Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer
- (2010) C Papadaki et al. BRITISH JOURNAL OF CANCER
- CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
- (2010) Y. Xu et al. CANCER RESEARCH
- Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo
- (2010) Xia Zhang et al. CANCER SCIENCE
- RB-pathway disruption in breast cancer
- (2010) Adam Ertel et al. CELL CYCLE
- First-line chemotherapy with or without biologic agents for metastatic breast cancer
- (2010) Claudia Andreetta et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Upstream Regulation of the Hippo Size Control Pathway
- (2010) Felix A. Grusche et al. CURRENT BIOLOGY
- Hippo signaling: growth control and beyond
- (2010) G. Halder et al. DEVELOPMENT
- BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications
- (2010) Rebecca J. Linger et al. FEBS Journal
- Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP
- (2010) A. M. Vigneron et al. GENES & DEVELOPMENT
- Hippo signaling at a glance
- (2010) Bin Zhao et al. JOURNAL OF CELL SCIENCE
- The hippo pathway in biological control and cancer development
- (2010) Siew Wee Chan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
- (2010) Karen A. Johnson et al. SEMINARS IN ONCOLOGY
- TAp63α Mediates Chemotherapeutic Agent-Induced Apoptosis in Human Bone Marrow Mesenchymal Stem Cells
- (2010) Chunhua Lu et al. STEM CELLS AND DEVELOPMENT
- High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy
- (2009) D. Trere et al. ANNALS OF ONCOLOGY
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
- (2009) Alessandra Ianari et al. CANCER CELL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting
- (2009) P. Lunghi et al. CLINICAL CANCER RESEARCH
- A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
- (2009) Britta Stordal et al. CURRENT CANCER DRUG TARGETS
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray
- (2009) Stacy Visser et al. GENE
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein
- (2009) Massimo Derenzini et al. JOURNAL OF PATHOLOGY
- ErbB2-Mediated Src and Signal Transducer and Activator of Transcription 3 Activation Leads to Transcriptional Up-Regulation of p21Cip1 and Chemoresistance in Breast Cancer Cells
- (2009) V. S. Hawthorne et al. MOLECULAR CANCER RESEARCH
- Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death
- (2009) Stefania Gonfloni et al. NATURE MEDICINE
- PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
- (2009) Q Sun et al. ONCOGENE
- Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
- (2008) M. Kawahara et al. BLOOD
- Down-regulation of Mammalian Sterile 20-Like Kinase 1 by Heat Shock Protein 70 Mediates Cisplatin Resistance in Prostate Cancer Cells
- (2008) A. Ren et al. CANCER RESEARCH
- PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab
- (2008) M. Jhawer et al. CANCER RESEARCH
- Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
- (2008) Helen M. Coley CANCER TREATMENT REVIEWS
- Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure
- (2008) M. Derenzini et al. CLINICAL CANCER RESEARCH
- Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
- (2008) R. Lazzarini et al. CLINICAL CANCER RESEARCH
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
- (2008) Aaron J. Schetter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
- Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage
- (2008) Dan Levy et al. MOLECULAR CELL
- Retinoblastoma protein modulates gankyrin–MDM2 in regulation of p53 stability and chemosensitivity in cancer cells
- (2008) W Qiu et al. ONCOGENE
- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions
- (2008) J Wen et al. ONCOGENE
- TP53 Status and Response to Chemotherapy in Breast Cancer
- (2008) Philippe Bertheau et al. PATHOBIOLOGY
- Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
- (2008) Laura Fontana et al. PLoS One
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now